[Federal Register Volume 74, Number 226 (Wednesday, November 25, 2009)]
[Notices]
[Page 61694]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-28289]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Clinical 
Trial Grant Review.
    Date: December 8, 2009.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Eric H. Brown, PhD, Scientific Review Officer, 
National Institute of Arthritis, Musculoskeletal and Skin Diseases, 
National Institutes of Health, 6701 Democracy Blvd., Room 824, Msc 
4872, Bethesda, MD 20892-4872, (301) 594-4955,[email protected].

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Providing 
Radiologic Outcomes for the Osteoarthritis Initiative.
    Date: December 16, 2009.
    Time: 10 a.m. to 11:30 a.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Charles N. Rafferty, PhD, Chief, Review Branch, 
National Institute of Arthritis, Musculoskeletal and Skin Diseases, 
National Institutes of Health, 6701 Democracy Boulevard, Suite 800, 
Bethesda, MD 20817, 301-534-4952, [email protected].
    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Clinical 
Outcome Instrument Development.
    Date: January 26, 2010.
    Time: 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Michael L. Bloom, PhD., MBA, Scientific Review 
Officer, National Institute of Arthritis, Musculoskeletal and Skin 
Diseases, National Institutes of Health, 6701 Democracy Blvd.; Room 
820, MSC 4872, Bethesda, MD 20892-4872, 301-594-4953, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research; 93.701, ARRA 
Related Biomedical Research and Research Support Awards, National 
Institutes of Health, HHS)

    Dated: November 19, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-28289 Filed 11-24-09; 8:45 am]
BILLING CODE 4140-01-P